Trulicity
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.trulicity.comRevenue
<$5 MillionIndustry
About Trulicity
Is Trulicity your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Trulicity recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Trulicity
Click to see if Trulicity had a recent Job posting/layoffs
Product Launch: Get notified when Trulicity launches new products
Check if Trulicity has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Trulicity, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Trulicity is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Trulicity has new funding data
Recommended Actions
Reach out to Masked Content who joined Trulicity as Masked Content
Find more new buyers
Compare Similar Companies to Trulicity
Compare insights from companies similar to Trulicity, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Trulicity is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Trulicity is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Trulicity.
Trulicity Tech Stack
A closer look at the technologies used by Trulicity
Trulicity News & Media
Trulicity® (dulaglutide) is the first and only type 2 diabetes medicine approved to reduce cardiovascular events in adults with and without established cardiovascular disease
The U.S. Food and Drug Administration (FDA) has approved Trulicity® (dulaglutide) for the reduction of major adverse cardiovascular events (MACE) in adults with type 2 diabetes who have established cardiovascular (CV) disease or multiple cardiovascular risk factors. This decision makes Eli Lilly and Company's (NYSE: LLY) Trulicity the first and only type 2 diabetes medicine approved to reduce the risk of MACE for both primary and secondary prevention populations.*
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Trulicity
Onceweekly Trulicity is a type 2 diabetes medication that helps your body release its own insulin and can help improve your A1C and blood sugar numbers. For people living with T2DM, Trulicity lowers the risk of CV events like heart attack, stroke and CV death in people with known heart disease or multiple risk factors.... Read More